Vimarsana
Biggest News Aggregation in the World

Page 31 - Work Productivity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Work Productivity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Work Productivity Today - Breaking & Trending Today

Improvements in Ankylosing Spondylitis Patient-Reported Outcomes Linked to Enhanced Work Productivity - Vimarsana News

Improvements in Ankylosing Spondylitis Patient-Reported Outcomes Linked to Enhanced Work Productivity

Incremental improvements in patient-reported outcomes are linked to enhancements in work productivity and daily life in individuals with AS.

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) - Vimarsana News

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

The STRIDE study did not meet its primary or secondary efficacy endpoint The company to suspend mavodelpar development and implement a workforce reduction IRVINE, Calif., Dec. 14, 2023 -- Reneo...

Study Shows How Sleep Affects Work for Those With Neurological Conditions - Vimarsana News

Study Shows How Sleep Affects Work for Those With Neurological Conditions

While past studies have shown the connection between poor sleep and job performance, this research dives deeper into the experience of this specific population.

Source: ajmc.com
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary ... - Vimarsana News

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary ...

The STRIDE study did not meet its primary or secondary efficacy endpoint

Increased Prurigo Nodularis Severity Linked to Increased Disease Burden - Vimarsana News

Increased Prurigo Nodularis Severity Linked to Increased Disease Burden

This web-based research is the first conducted to assess the burden of disease and treatment satisfaction among those in Japan with PN.